Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The objective of this post-marketing surveillance study is to collect safety, efficacy and
usage data on botulinum injection in subjects with upper or lower limb spasticity on the
long-term use in clinical practice and to identify the factors affecting the safety or
efficacy.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA